Zeria Pharmaceutical (Japan)
In research, Zeria Pharmaceutical (Japan) stands highest in Health Sciences (#20,294 of 20,462 worldwide), over all time.
- World rank, all time
- #37,987 of 42,892
- Rank in Japan
- #1,717 of 2,112
- Research works
- 281 ▼ 13% vs 2013–17
- Citations
- 3.7k 13.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 43% world 28%
What is Zeria Pharmaceutical (Japan) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #20,294 of 20,462 | 4.9% | 127 |
Each strip is that field’s whole ranked pool, with the notch where Zeria Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.5×. Every wedge is a field page.
- Immunology and Microbiology 16.5×
- Pharmacology, Toxicology and Pharmaceutics 13.2×
- Business, Management and Accounting 4.3×
- Mathematics 3.0×
- Medicine 1.9×
- Nursing 1.8×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Economics, Econometrics and Finance 1.2×
- Agricultural and Biological Sciences 1.0×
- Social Sciences 0.6×
- Materials Science 0.5×
Who are the top researchers at Zeria Pharmaceutical (Japan)?
Ranked on the composite score, Mineo Takei and Tadashi Kurimoto lead among researchers whose main affiliation is Zeria Pharmaceutical (Japan).
- 1 Mineo Takei Japan · #1,532,019 worldwide 9 citations · 17 works
- 2 Tadashi Kurimoto Japan · #1,568,164 worldwide 0 citations · 15 works
Which keywords describe research at Zeria Pharmaceutical (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Oxidative Stress, Synthesis, Antioxidant, Cancer, Metabolism, Neuroprotection and Stress.
- Neuropeptides
- Carnosine
- Cytochrome P450
- Intestinal Barrier
- Hypertension
- Helicobacter pylori
- Gastric Cancer
- Anticancer
- Metabolic Regulation
- Diabetes
- Biological Evaluation
- Cardiovascular Risk
- Antibiotic Resistance
- Aging
- Pharmacology
- Drug Discovery
- Neuroprotection
- Epidemiology
- Synthesis
- Oxidative Stress
- Inflammation
- Cancer
- Antioxidant
- Metabolism
- Stress
- Nuclear Receptors
- Depression
- Heterocycles
- Metabolic Syndrome
- Pathogenesis
- Angiogenesis
- Antioxidant Activity
- Prevention
- Cell Signaling
- Eradication Therapy
- Anticancer Agents
- Probiotics
- Antimicrobial
- Exercise Performance
- ß-Alanine Supplementation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation47▲ 7.2×41 topics
- Oxidative Stress27▲ 5.2×34 topics
- Cancer20▲ 5.1×26 topics
- Synthesis18▲ 11×14 topics
- Antioxidant17▲ 8.8×15 topics
- Epidemiology16▲ 1.40×32 topics
- Metabolism13▲ 7.3×18 topics
- Neuroprotection11▲ 10×8 topics
- Stress10▲ 8.8×5 topics
- Drug Discovery10▲ 8.5×7 topics
- Nuclear Receptors9▲ 18×4 topics
- Pharmacology9▲ 9.6×8 topics
- Depression9▲ 4.1×4 topics
- Aging8▲ 5.8×6 topics
- Heterocycles8▲ 17×5 topics
- Antibiotic Resistance8▲ 7.4×5 topics
- Metabolic Syndrome8▲ 3.5×8 topics
- Cardiovascular Risk8▲ 8.4×5 topics
- Pathogenesis8▲ 5.1×5 topics
- Biological Evaluation8▲ 22×6 topics
- Angiogenesis7▲ 6.4×8 topics
- Diabetes7▲ 5.1×11 topics
- Antioxidant Activity7▲ 4.6×13 topics
- Metabolic Regulation7▲ 8.9×4 topics
- Prevention7▲ 6.3×4 topics
- Anticancer7▲ 13×7 topics
- Cell Signaling7▲ 7.2×8 topics
- Gastric Cancer7▲ 19×2 topics
- Eradication Therapy7▲ 49×1 topic
- Helicobacter pylori7▲ 49×1 topic
- Anticancer Agents7▲ 9.2×7 topics
- Hypertension7▲ 6.6×6 topics
- Probiotics6▲ 9.2×4 topics
- Intestinal Barrier6▲ 19×2 topics
- Antimicrobial6▲ 8.7×5 topics
- Cytochrome P4506▲ 29×2 topics
- Exercise Performance6▲ 32×2 topics
- Carnosine6▲ 57×1 topic
- ß-Alanine Supplementation6▲ 57×1 topic
- Neuropeptides6▲ 19×2 topics
Which research topics does Zeria Pharmaceutical (Japan) publish most on?
By volume in 2022–2025: Financial Analysis and Corporate Governance, Immunotherapy and Immune Responses, Immune Cell Function and Interaction and Immune cells in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Financial Analysis and Corporate Governance Accounting 1 works
- 2 Immunotherapy and Immune Responses Immunology 0 works
- 3 Immune Cell Function and Interaction Immunology 0 works
- 4 Immune cells in cancer Immunology 0 works
- 5 Corporate Social Responsibility Disclosure Gender Studies 0 works
- 6 Hemoglobinopathies and Related Disorders Genetics 0 works
- 7 Iron Metabolism and Disorders Hematology 0 works
- 8 Management and Optimization Techniques Strategy and Management 0 works
- 9 SMEs Development and Digital Marketing Demography 0 works
- 10 Cancer Research and Treatments Biotechnology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Zeria Pharmaceutical (Japan)'s research output changed?
Output in 2018–2022 was 13% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.